Latest updates for Avexitide

Fresh curated links around avexitide are collected here so marketers can spot useful updates and turn timely ideas into posts faster.

Recent items include:

  • GLP-1 reduces rates of post-bariatric hypoglycemia
  • Amylyx readies approval push after GLP-1 inhibitor halves blood sugar crashes in ph. 3 win
  • Amylyx Plans FDA Filing After GLP-1 Drug Hits Trial Goals in Rare Metabolic Condition

Post angles to try

Share the most useful takeaway for your audience.
Turn one article into a quick practical checklist.
Ask your audience how this shift affects their work.
Turn angles into scheduled posts

Fresh articles and ideas

Recent curated links from global sources. Generate one free draft from any story, then use SocialBu to schedule and refine your content calendar.

healio.com /3 weeks ago

GLP-1 reduces rates of post-bariatric hypoglycemia

A once-daily GLP-1 receptor agonist decreased events of level 2 and level 3 hypoglycemia for adults after Roux-en-Y gastric bypass, according to topline results from a phase 3 tria...

Read source
fiercebiotech.com /3 weeks ago

Amylyx readies approval push after GLP-1 inhibitor halves blood sugar crashes in ph. 3 win

Amylyx Pharmaceuticals’ $35 million bet on the GLP-1 receptor antagonist avexitide appears to have paid off, with the molecule cutting the number of dangerous blood sugar crashes b...

Read source
medcitynews.com /3 weeks ago

Amylyx Plans FDA Filing After GLP-1 Drug Hits Trial Goals in Rare Metabolic Condition

Amylyx Pharmaceuticals’ avexitide led to statistically significant and clinically meaningful reductions in hypoglycemic events in patients with post-bariatric hypoglycemia (PBH). T...

Read source
cafepharma.com /2 weeks ago

Baxfendy Approval

Baxfendy Approval Anonymous (not verified) Sat, 08/22/2026 - 06:38 field_thread_url https://cafepharma.com/boards/threads/baxfendy-approval.716800/...

Read source

Turn fresh research into a full content calendar

Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.

Sources covering Avexitide

cafepharma.com

Recent coverage from public sources
Public source

medcitynews.com

Recent coverage from public sources
Public source

fiercebiotech.com

Recent coverage from public sources
Public source

healio.com

Recent coverage from public sources
Public source